Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 20, Issue 1, 2002, Pages 247-253

  Depierre, A ^a   Milleron, B ^a   Moro Sibilot, D ^a   Chevret, S ^a   Quoix, E ^a   Lebeau, B ^a   Braun, D ^a   Breton, J L ^a   Lemarie E ^a   Gouva, S ^a   Paillot, N ^a   Brechot J M ^a   Janicot, H ^a   Lebas, F X ^a   Terrioux, P ^a   Clavier, J ^a   Foucher, P ^a   Monchatre M ^a   Coetmeur D ^a   Level, M C ^a   Leclerc, P ^a   Blanchon, F ^a   Rodier, J M ^a   Thiberville, L ^a   Villeneuve, A ^a   Westeel, V ^a   Chastang, C ^a   more..

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; IFOSFAMIDE; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DRUG INDUCED DISEASE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IFOSFAMIDE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE;

EID: 0036139728     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.1.247     Document Type: Article

References (23)

1. Cancer statistics
2. The role of surgery in N2 lung cancer
3. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate
4. Critical analysis of neoadjuvant therapy for stage IIIa non-small-cell lung cancer
5. A new international staging system for lung cancer
6. Non-parametric estimation from incomplete observations
7. Evaluation of survival data and two new rank order statistics arising in its consideration
8. Regression models and life tables
9. Modern thirty-day operative mortality for surgical resections in lung cancer
10. The importance of surgery to non-small-cell carcinoma of lung with mediastinal lymph node metastasis
11. Surgical treatment of non-small-cell lung cancer by stage
12. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
13. Randomized trial of neoadjuvant therapy for lung cancer. Interim analysis
14. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer
15. The role of multimodality therapy in locoregional non-small-cell lung cancer
16. Phase II study of gemcitabine plus cisplatin as induction chemotherapy regimen for patients with stage IIIA-IIIB non-small-cell lung cancer (NSCLC). Preliminary report
17. Induction chemotherapy before surgery for early-stage lung cancer. A novel approach-Bimodality Lung Oncology Team
18. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer. A 7-year assessment of a randomized controlled trial
19. Chemotherapy plus surgery versus surgery alone in non-small-cell lung cancer
20. Chemotherapy and surgery versus surgery alone in non-small-cell lung cancer
21. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
22. Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma